We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03677934
Brief Title: A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)

First Submitted : September 11, 2018
First Submitted that Met QC Criteria : September 18, 2018
First Posted : September 19, 2018

Results First Submitted : November 18, 2021
Results First Posted with QC Comments : December 17, 2021
Results First Submitted that Met QC Criteria : February 28, 2022
Results First Posted : March 25, 2022

Certification/Extension First Submitted : March 24, 2021
Certification/Extension First Submitted that Met QC Criteria : February 28, 2022
Certification/Extension First Posted : March 25, 2022

Last Update Submitted that Met QC Criteria : September 6, 2022
Last Update Posted : October 4, 2022